However, loss of Raptor in tumor-free endothelium did not significantly change CD31+ vessel intensity or α-SMA+ pericyte coverage in normal tissues (Supplemental Figure 2, A–D), indicating that mTORC1 signaling is preferentially required for tumor endothelium. This evidence concerns the gene ACTA1 and neoplasm.